Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy

Neurology India

Volumn 52, Issue 4, 2004, Pages 457-462

  Padma, M V ^a,b   Simkins, Robert ^a   White, Phillip ^a   Satter, Martin ^a   Christian, Brad T ^a   Dunigan, Kelly ^a   Lee, Candi ^a   Jacobs, M ^a   Mukherjee, J ^a   Shi, B ^a   Mantil, Joseph C ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

11C flumazenil positron emission tomography (PET); Intractable TLE; Magnetic resonance imaging (MRI); PET; Temporal lobe epilepsy (TLE)

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBAMAZEPINE; CARBON 11; ETIRACETAM; FELBAMATE; FLUMAZENIL; FLUMAZENIL C 11; FLUORODEOXYGLUCOSE F 18; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; ZONISAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EPILEPTIC FOCUS; FEMALE; HIPPOCAMPAL SCLEROSIS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; STUDENT T TEST; SYMPTOM; TEMPORAL LOBE EPILEPSY; TUBEROUS SCLEROSIS;

ADULT; ELECTROPHYSIOLOGY; EPILEPSY, TEMPORAL LOBE; FEMALE; FLUMAZENIL; FLUORODEOXYGLUCOSE F18; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 19944425999     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jackson GD, Berkovic SF, Tress BM, Kalnins AM, Fabinyi GC, Bladin PF. Hippocampal sclerosis can be reliably detected by magnetic resonance imaging. Neurology 1990;40:1869-75.
2. Jackson GD, Berkovic SF, Duncan JS, Connelly R. Optimizing the diagnosis of hippocampal sclerosis using MR imaging. Am J Neuroradiol 1993;14:753-62.
3. Van Paesschen W, Connelly A, King MD, Jackson GD, Duncan JS. The spectrum of hippocampal sclerosis: A quantitative magnetic resonance imaging study. Ann Neurol 1997;41:41-51.
4. Berkovic SF, McIntosh AM, Kalnins RM, Jackson GD, Fabinyi GCA, Brazenor GA, et al. Preoperative MRI predicts outcome of temporal lobectomy. An acturial analysis. Neurology 1995;45:1358-63.
5. Sisodiya, SM, Moran N, Free SL, Kitchen ND, Stevens JM. Harkness LUF, et al. Correlation of widespread preoperative magnetic resonance imaging changes with unsuccessful surgery for hippocampal sclerosis. Ann Neurol 1997:41:490-6.
6. Kuzniecky R, Garcia JH, Faught E, Morawetz AB. Cortical dysplasia in temporal lobe epilepsy: Magnetic resonance imaging correlations. Ann Neurol 1991;29:293-8.
7. Savic I, Svanborg E, Thorell JO. Cortical benzodiazepine receptor changes are related to frequency of partial seizures: A positron emission tomography study. Epilepsia 1996;37:236-44.
8. Arnold S, Schlaug G, Niemann H, Ebner A, Luders H, Witte OW, et al. Topography of interictal glucose hyometabolism in unilateral mesiotemporal epilepsy. Neurology 1996;46:1422-30.
9. Savic I, Ingvar M, Stone-Blander S. Comparison of 11C-flumazenil and 18F-FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 1993;56:615-21.
10. Juhasz C, Nagy F, Watson C, da Silva ER, Muzik O, Chugani DC, et al. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Neurology 1999;53:2037-45.
11. Koepp MJ, Hand KS, Labbe C, Richardson MP, Van Paesschen LU, Baird VH, et al. In vivo [11C]flumazenil-PET correlates with ex vivo [3H] flumazenil autoradiography in hippocampal sclerosis. Ann Neurol 1998;43:618-26.
12. Maziere M, Hantraye P, Prenant C. Synthesis of an ethyl 8-fluoro-5,6- dihydro-5-[11C] methyl-6-oxo-4H-imidaz[1,5-a][1,4]benzodiazepine-3- carboxylate(RO 15.1788-11C): A specific radioligand for the in vivo study of central benzodiaxcpine receptors by positron emission tomography. Int J Appl Radiat Isot 1984;35:973-6.
13. Koepp MJ, Hammers A, Labbe C, Woermann FG, Brooks DJ, Duncan JS. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000;54:332-9.
14. Koepp MJ, Richardson MP, Brooks DJ, Poline JB, Van Paesschen W, Friston KJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain 1996;119:1677-87.
15. Koepp MJ, Labbe C, Richardson MP, Brooks DJ, Van Paesschen AV, Cunnigham W, et al. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997;120:1865-76.
16. Koepp MJ, Richardson MP, Labbe C, Brooks DJ, Cunnigham W, Ashburner J, et al. 11C-flumazenil PET, volumetric MRI and quantitative pathology in mesial temporal lobe epilepsy. Neurology 1997;49:764-73.
17. Richardson MP, Koepp MJ, Brooks DJ, Fish DR, Duncan JS. Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: An 11C-Flumazenil PET study. Ann Neurol 1996;40:188-98.
18. Burdette DE, Sakurai SY, Henry TR, Ross DR, Pennell B, Frey KR, et al. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology 1995;45:934-41.
19. Richardson MP, Friston KJ, Sisodiya SM, Koepp MJ, Ashburner J, Free SL, et al. Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. Brain 1997;120:1961-73.
20. Labbe C, Koepp M, Ashburner J. Absolute PET quantification with correction for partial volume effects within cerebral structures. In: Carson C, Daube-Witherspoon M, Herseovitch P. editors. Quantitative functional brain imaging with positron emission tomography, San Diego, CA: Academic Press; 1998:59-66.
21. Lamusuo S, Pitkaneu A, Jutila L, Ylinen A, Partanen K, Kalvianen R, et al. [11C]flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy. Neurology 2000;54:2252-60.
22. Juhasz C, Chugani DC, Muzik O, Watson C, Shah J, Shah A, et al. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Neurology 2000;55:825-35.
23. Morrell F. Secondary epileptogenesis in man. Arch Neurol 1985;42:318-35.
24. Ryvlin P, Bouvard S, Le Bars D, Mauguiere F. Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy. Neurology 1999;53:1882-8.
25. Hammers A, Koepp MJ, Labbe C, Brooks DJ, Thom M, Cunnigham VJ, et al. Neocortical abnormalities of [11C] flumazenil PET in mesial temporal lobe epilepsy. Neurology 2001;56:897-906.